Join
Live feed
·
PRReleasevia Quantisnow
Brainstorm Cell Therapeutics Inc. logo

BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS

ByQuantisnow·Wall Street's wire, on your screen.
BCLI· Brainstorm Cell Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BCLI (Brainstorm Cell Therapeutics Inc.) and more on Quantisnow.